Otonomy, Inc.
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- Private
- Established
- 2008-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.otonomy.com
OTO-104 for the Treatment of Meniere's Disease
- First Posted Date
- 2011-08-09
- Last Posted Date
- 2015-09-03
- Lead Sponsor
- Otonomy, Inc.
- Target Recruit Count
- 154
- Registration Number
- NCT01412177
- Locations
- ๐บ๐ธ
UC Health Otolaryngology - Head and Neck Surgery, Cincinnati, Ohio, United States
๐บ๐ธMany sites in US and Canada. Refer to the contact info listed below., San Diego, California, United States
OTO-104 for Meniere's Disease
Phase 1
Completed
- Conditions
- Meniere's Disease
- Interventions
- Drug: OTO-104 (steroid) 3 mgDrug: PlaceboDrug: OTO-104 (steroid) 12 mg
- First Posted Date
- 2010-03-10
- Last Posted Date
- 2011-06-08
- Lead Sponsor
- Otonomy, Inc.
- Target Recruit Count
- 44
- Registration Number
- NCT01084525
- Locations
- ๐บ๐ธ
Colorado Otolaryngology Associates, Colorado Springs, Colorado, United States
๐บ๐ธPiedmont Medical Research, Winston-Salem, North Carolina, United States
๐บ๐ธHouse Ear Institute, Los Angeles, California, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath